Lung Adenocarcinoma - from pathology to therapeutic implications - Pathologist viewpoint

被引:0
|
作者
Travis, W. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
387
引用
收藏
页码:S87 / S87
页数:1
相关论文
共 50 条
  • [21] MicroRNA-mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review)
    Liu, Jiye
    Zhang, Fei
    Wang, Jiahe
    Wang, Yibing
    ONCOLOGY REPORTS, 2023, 50 (06)
  • [22] Tumor microenvironment and drug resistance in lung adenocarcinoma: molecular mechanisms, prognostic implications, and therapeutic strategies
    Cao, Qianqian
    Li, Chenxuan
    Li, Ying
    Kong, Xiangjing
    Wang, Shoushi
    Ma, Jun
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [23] Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma
    Liu, Ke
    Guo, Jintao
    Liu, Kuai
    Fan, Peiyang
    Zeng, Yuanyuan
    Xu, Chaoqun
    Zhong, Jiaxin
    Li, Qiyuan
    Zhou, Ying
    EBIOMEDICINE, 2018, 36 : 196 - 208
  • [24] Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinoma
    Kneuertz, Peter J.
    Carbone, David P.
    D'Souza, Desmond M.
    Shilo, Konstantin
    Abdel-Rasoul, Mahmoud
    Zhao, Weiqiang
    Williams, Terrance M.
    Jones, Daniel
    Merritt, Robert E.
    LUNG CANCER, 2020, 143 : 60 - 66
  • [25] THE REGISTRY OF VETERINARY PATHOLOGY FROM THE PRACTITIONERS VIEWPOINT
    ZEPP, CP
    ZEPP, CP
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1948, 112 (855) : 483 - 484
  • [26] Inflammasome biology, molecular pathology and therapeutic implications
    Awad, Fawaz
    Assrawi, Eman
    Louvrier, Camille
    Jumeau, Claire
    Georgin-Lavialle, Sophie
    Grateau, Gilles
    Amselem, Serge
    Giurgea, Irina
    Karabina, Sonia-Athina
    PHARMACOLOGY & THERAPEUTICS, 2018, 187 : 133 - 149
  • [27] Pathology of pain and its implications for therapeutic interventions
    Cao, Bo
    Xu, Qixuan
    Shi, Yajiao
    Zhao, Ruiyang
    Li, Hanghang
    Zheng, Jie
    Liu, Fengyu
    Wan, You
    Wei, Bo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [28] Lung adenocarcinoma pathology stages related gene identification
    Sun, Gaozhong
    Zhao, Tongwei
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 17 (01) : 737 - 746
  • [29] Identification of a novel therapeutic target in lung adenocarcinoma
    Enfield, Katey S. S.
    Marshall, Erin A.
    Anderson, Christine
    Ng, Kevin W.
    Rahmati, Sara
    Xu, Zhaolin
    MacAulay, Calum E.
    Lam, Stephen
    Lockwood, William W.
    Chari, Raj
    Karsan, Aly
    Jurisica, Igor
    Lam, Wan L.
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [30] Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    TUMORI JOURNAL, 2024, 110 (02): : 88 - 95